Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
about
Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@ast
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@en
type
label
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@ast
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@en
prefLabel
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@ast
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@en
P2093
P2860
P356
P1433
P1476
Replication Study: Inhibition ...... ment for MLL-fusion leukaemia.
@en
P2093
Alan Kosaka
Gwenn Danet-Desnoyers
Juan Jose Fung
Xiaochuan Shan
P2860
P356
10.7554/ELIFE.25306
P407
P577
2017-06-27T00:00:00Z